# Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD

> **NCT01965366** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 27 (actual)

## Conditions studied

- PTSD

## Interventions

- **BEHAVIORAL:** Virtual reality exposure therapy
- **DRUG:** 0.5 mg DEX

## Key facts

- **NCT ID:** NCT01965366
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-03
- **Final completion:** 2017-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965366, "Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01965366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*